DEAR GUESTS,
THIS IS THE LARGEST GATHERING
OF ALL LIFE SCIENCES
SPECIALISTS IN THE ENTIRE
CENTRAL AND EASTERN EUROPE.
Since the future belongs to the bio-economy which
is going to be based on the concrete results of the
Life Sciences sector, it becomes crucial to turn it into
a national priority. In order to improve international
competitiveness and economic vibrancy in Lithuania,
governmental institutions, and the whole science and
business ecosystem join their forces to establish an open
and friendly environment for attracting the progressive
mind, break-through ideas and forming the new effective
networks with partners from all over the world.
Lithuania already hosts one of the most innovative
hubs in Europe: 16 academic institutions, 15 most
competent R&D centers along with the pool of over
15,000 specialists and researchers as well as nearly
200 companies operating in the sector, science parks,
and innovation valleys. They provide the country with
the most necessary tools to succeed in becoming one of
the top high tech innovation centers in Europe or even
the world. A nation with a population of only 3 million
is among the top EU countries by the percentage of
specialists with higher education. Universities currently
train in physics and life sciences almost 9000 students,
1200 of these prospective inventors graduate every year.
We have increased state financed places at universities
and colleges for life science disciplines to ensure
intellectual capacity for future growth. This decision
is followed by prioritizing respective disciplines in the
curriculum of high schools nation-wide.
It is important to highlight that The Forum enjoys high
participation by local and international corporations
and investors who attend this conference to notice
tomorrow’s potential in today’s products. We are
committed to promote a closer international cooperation
between science and business in the fields of
biotechnology, medical equipment, devices and pharmacy.
The Forum also provides a platform for startups to meet
ˆ
It is my honor and privilege to invite you to the third
international Forum "Life Sciences Baltics 2016",
which will be held in Vilnius, Lithuania, on September
14-15, 2016. This bi-annual international science and
business conference is the largest gathering of all life
sciences specialists in the entire Central and Eastern
Europe. Furthermore, with the special focus on three
Baltic countries – Lithuania, Latvia and Estonia – the
forum attracts numerous delegations from the leading
countries, which are interested in discovering the Baltic
region potential in the field of life sciences.
ALGIRDAS BUTKEVICIUS, PRIME MINISTER,
REPUBLIC OF LITHUANIA
up with partners and investors. It is the ultimate place to
be exposed in the clinical trials, meet the venture capital
experts, boost ideas and begin cooperating further.
Join over 1000 business leaders and scientists at
the Forum, meet potential partners, discover new
opportunities, and share ideas for the new and prosperous
future of humanity.
Our country would be delighted to welcome you at "Life
Sciences Baltics 2016".
WHY BALTICS?
BSR
110 million
ESTONIA
LATVIA
TREND-SETTER
DESTINATIONS IN EU
EUROPE’S PRIME LOCATION
AND INFRASTRUCTURE
Crossroads of North, East and West
3 Pam-European transport corridors
4 modern international airports
LITHUANIA
CIS
250 million
EU
340 million
*BSR – The Baltic Sea Region
CIS – The Commonwealth of Independent State
WHY BALTICS?
EU STRUCTURAL FUNDS. Cooperation with
Baltic companies enables access to the EU
structural funds (only in Lithuania up to 1
billion EUR for the period of 2014-2020)
COMPETITIVE SALARIES. Gross salaries in the
life sciences sector are 2 to 3 times more
competitive compared to Western Europe
START-UPS. A GROWING NUMBER
OF START-UPS AND SMES HAVE
ADVANCED PRODUCT PORTFOLIO AND
WOULD LIKE TO ATTRACT PARTNERS
FOR FINANCIAL INVESTMENTS
TALENTS. Region offers highly qualified
talent pool
TAXES. Astonishing tax environment
for R&D activities
WHY BALTICS?
ESTONIA:
LATVIA:
LITHUANIA:
1ST COUNTRY TO OFFER E-RESIDENCY
- A TRANSNATIONAL DIGITAL IDENTITY
AVAILABLE TO ANYONE IN THE WORLD
INTERESTED IN ADMINISTERING A
LOCATION-INDEPENDENT BUSINESS
ONLINE
Data visualization has reached new peaks with the
help of Latvians (Infogr.am)
Fastest public Wi-Fi in the world and leading upload
broadband speed in the EU and top 5 globally
1st country in the world to hold nation-wide
elections using i-Voting
More than 90% of the people complete their
income tax return over the internet
Libraries house not only numerous hard copy books,
but are being digitized and uploaded online
QUEUING IS AVOIDED BY USING ALMOST
100 STATE AND LOCAL GOVERNMENT
E-SERVICES
1ST IN ENTREPRENEURSHIP BY IMD
WORLD COMPETITIVENESS RANKING
Highest ICT literacy in the EU – 97% of students
obtaining ICT skills in secondary schools
1st in CEE in University-Industry collaboration in
R&D
LIFE SCIENCES IN ESTONIA:
1866
ACADEMIC
EXPERTS
AROUND
150
COMPANIES
IN BIOTECHNOLOGY AND LIFE SCIENCES
THERE ARE 4 BIOMEDICAL
CLUSTERS AND 3 BIOMEDICAL
COMPETENCE CENTERS IN
ESTONIA
28%
66
PH.D. GRADUATES PER YEAR
507
THE ANNUAL TURNOVER
OF THE ESTONIAN
BIOTECHNOLOGY IS
GROWING AT A RATE OF
28%
MASTER GRADUATES PER YEAR
1.841
9
UNIVERSITIES AND
RESEARCH INSTITUTES
WITH R&D IN
BIOTECHNOLOGY AND
LIFE SCIENCES
BACHELOR GRADUATES PER YEAR
LEADING SUBSECTOR:
GENETICS & HEREDITY,
CREATING 33,7% OF
INDUSTRY PRODUCTION
33,7%
LIFE SCIENCES IN LATVIA:
LEADING SUBSECTOR:
PHARMACEUTICALS. IT IS THE LARGEST
INDUSTRY SUB-SECTOR, CREATING
33% OF INDUSTRY PRODUCTION
33%
NR. 4
LIFE SCIENCE SECTOR
IS 4TH BY TURNOVER
AMONG MANUFACTURING
INDUSTRIES IN LATVIA
50
TOTAL NUMBER OF LIFE
SCIENCES COMPANIES, R&D
CENTERS, UNIVERSITIES
CHEMICAL AND PHARMACEUTICAL
SECTOR GIVES 9.4% (2010) OF
GROSS DOMESTIC PRODUCT AND
ACCOUNTS FOR 10% OF THE
TOTAL NATIONAL EXPORT
NOBEL PRIZE WINNER:
PAUL VALDEN WAS
NOMINATED TWICE FOR
THE NOBEL PRIZE AND IS
A FOUNDER OF PHYSICAL
ORGANIC CHEMISTRY
NOBEL PRIZE WINNER:
WILHELM OSTWALD IN
CHEMISTRY IN 1909 FOR
HIS WORK ON CATALYSIS,
CHEMICAL EQUILIBRIA AND
REACTION VELOCITIES
LIFE SCIENCES IN LITHUANIA
R&D SECTOR
ACHIEVED GROUND BREAKING
RESULTS IN THE FIELDS OF:
Labor productivity in pharmaceuticals
sector is almost 5 times (in 2011)
higher than the overall economy’s labor
productivity
PHARMACEUTICAL PROTEINS
CHEMISTRY
BIOCHEMISTRY OF ENZYMES
AND NUCLEIC ACIDS
MOLECULAR BIOLOGY OF
PROKARYOTE AND EUKARYOTE
CURRENT SPOTLIGHT OF RESEARCH
POINTED ON BIOINFORMATICS
PRODUCTION IS EXPORTED TO
OVER 100 COUNTRIES
16 RESEARCH CENTRES
cooperating with both domestic and
foreign biotechnology companies and
universities
3x
FASTER GENES CUT,
BASED ON ADVANCED
ENZYMES METHODOLOGY,
FOUND IN LITHUANIA
15 000
R&D researchers and scientists
in various fields
EXPENDITURES FOR R&D
grew by 14% in 2014
TOTAL ANNUAL
REVENUES EXCEED:
R&D ORIENTED:
€ 75 000 000
23%
ANNUAL
GROWTH
10TH IN THE WORLD
FOR R&D PERSONNEL PER CAPITA
(MAD, 2013)
11% YEAR ON YEAR RISE IN R&D
EXPENDITURE SINCE 2005
(LITHUANIAN STATISTICS, 2013)
LASERS
LITHUANIA, WITH 10% OF
THE GLOBAL MARKET, IS ONE
OF THE MAIN EXPORTER OF
FEMTOSECOND* LASERS
SYSTEMS IN THE WORLD
*FEMTOSECOND = 0.000 000 000 000 000 1 S.
80%
CLIENTS AND PARTNERS
OF LITHUANIAN LASER
MANUFACTURERS INCLUDE:
NASA
The Nuclear Research Centre in Israel
Rutherford Laboratories in England 80%
Berkeley University in the USA
The Livermore National Laboratory, etc
80% OF THE GLOBAL PRODUCTION
OF ULTRA-FAST PARAMETRIC
AMPLIFIERS
OF TOTAL LITHUANIAN LASER PRODUCTION
EXPORTED TO NEARLY 100 COUNTRIES
(KEY MARKETS: USA, GERMANY, JAPAN)
CONTINUOUS INDUSTRY
GROWTH REACHING 20%
PER YEAR
Laser manufacturing sector of
Lithuania shows a 15 - 20%
growth per year
15 - 20%
EVERY 10TH
SCIENTIFIC LASER USED IN
THE WORLD IS PRODUCED
IN LITHUANIA
MEDICAL DEVICES
EDUCATION
MEDICAL DEVICES EXPORTS
(incl. re-exports) more than
doubled since 2008
1ST
€ 177 M
2008
2012
-IN EU FOR SHARE OF GRADUATES IN
TOTAL POPULATION
€ 180 M
-IN CEE FOR QUALITY OF MATH AND
SCIENCE EDUCATION (WEF GLOBAL
COMPETITIVENESS REPORT, 20142015)
2014
MAIN EXPORT COUNTRIES ARE:
UNITED KINGDOM
FRANCE RUSSIA
SPAIN USA
Research areas include biomedical
diagnostics and monitoring systems,
efficiency research of electronic
security systems, analysis and
synthesis of electronic devices,
quality of electronic systems
“INDUSTRIAL ELECTRONICS, INCLUDING
MEDICAL AND DEFENSE ELECTRONICS HAS
BEEN A PREVALENT APPLICATION SECTOR
IN ELECTRONICS MANUFACTURING WITH
TELECOMMUNICATION EQUIPMENT BEING A KEY
GROWING SEGMENT“
9000
LIFE SCIENCE STUDENTS AT
UNIVERSITIES AND COLLEGES
1200
GRADUATES EACH YEAR
CLINICAL TRIALS
Clinical trials in Lithuania cover a
range of therapeutic areas
ENDOCRINOLOGY
GASTROENTEROLOGY
RHEUMATOLOGY
PULMONOLOGY
INFECTOLOGY
DERMATOLOGY
UROLOGY
PEDIATRIC
SURGERY
NEPHROLOGY
CARDIOLOGY
PSYCHIATRY
HEMATOLOGY
NEUROLOGY
ONCOLOGY
OPHTHALMOLOGY
BUSINESS-FRIENDLY
ENVIRONMENT
1200
STRATEGIC LOCATION
SINCE 2006 THERE WERE 1200
CLINICAL TRIALS ONGOING IN THE
COUNTRY
FAVORABLE TAX INCENTIVES FOR
INVESTMENTS INTO R&D INCLUDING:
90 INTERNATIONAL PHARMA
AND MEDICAL COMPANIES ARE
CONDUCTING CLINICAL TRIALS IN
LITHUANIA
TRIPLE DEDUCTION: expenses incurred
by companies while carrying out R&D
can be deducted from taxable income
tree times
SUPER-ACCELERATED DEPRECIATION: the
acquisition price of fixed assets used
in the R&D activities can be writtenoff within two years
INVESTMENTS INTO SUBSTANTIAL
TECHNOLOGICAL IMPROVEMENTS, entitle
companies to reduce taxable profits
by 50%
FIND MORE AT WWW.LSB2016.COM
LIFE SCIENCES BALTICS
NEW DESTINATION FOR LIFE
SCIENCES TREND-SETTERS
Within 2012 and 2014:
VISITORS
FROM
AROUND
40
COUNTRIES
1900
LIFE SCIENCES BALTICS 2016 FOCUS ON:
AGE-RELATED
DESEASES
BIO-BANKING
MOLECULAR
MEDICINE
ATTENDEES
PHARMACEUTICALS AND
BIOPHARMACEUTICALS
REGENERATIVE MEDICINE
MEDICAL
DEVICES
3000
B2B MEETINGS
EXHIBITORS
PRECLINICAL AND CLINICAL
TRIALS
TECHNOLOGY TRANSFER AND
INNOVATION MANAGEMENT
100
LITHUANIAN
AND FOREIGN
COMPANIES
WHY A MUST?
1
2
MORE THAN 1000 KEY SECTOR PLAYERS
AND DECISION MAKERS FROM MORE
THAN 40 COUNTRIES (INCLUDING
DELEGATIONS FROM US, ISRAEL, EU),
REGULATORY BODIES AND GOVERNMENT
REPRESENTATIVES
INVESTOR-READY STARTUPS
3rd Life Sciences Baltics 2016 is the only
international forum in the Baltic region for worldclass biotechnology, pharmaceutical and medical
experts from around the world, reoccurring every
two years.
3
NOBEL PRIZE WINNERS
AND GLOBALLY ACCLAIMED
SPEAKERS
5
FOCUS ON NETWORKING AND
ESTABLISHING PARTNERSHIPS
4
EU STRATEGY, DIRECTIONS AND
FUNDING OPPORTUNITIES
6
TALENT POOL AND STATE-OF-THEART SCIENTIFIC INFRASTRUCTURE
OF THE BALTIC COUNTRIES
It provides a unique opportunity to
explore the new horizons of partnerships,
exchange ideas and seek progress through
networking.
DISCOVER ENORMOUS POTENTIAL IN THE
FIELD OF LIFE SCIENCES IN LITHUANIA AND
THE BALTIC REGION – THE GATEWAY TO
EMERGING MARKETS
SAVE THE DATE!
SEPTEMBER 14-15, 2016
Enterprise Lithuania offers high quality services meeting
business needs and expectations. The knowledge and
expertise of our professional team, gained through direct
dealing with the country’s companies and exporters, will
help you to find the best and most reliable suppliers of
products, services and technologies in Lithuania. We
aim at finding a reliable and long-term partners. We
work locally, but thing globally. A multicultural approach
helps to better understand and evaluate the needs and
interests of foreign clients.
Main organizer:
To arrange a meeting please contact us:
[email protected], www.lsb2016.com
For more information visit: www.enterpriselithuania.com